Health & Life Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 10, 2022
Share
Health & Life Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 180.34 million compared to TWD 196.45 million a year ago. Net income was TWD 0.337 million compared to net loss of TWD 28.85 million a year ago. Basic earnings per share from continuing operations was TWD 0.01 compared to basic loss per share from continuing operations of TWD 0.61 a year ago. Diluted earnings per share from continuing operations was TWD 0.01 compared to diluted loss per share from continuing operations of TWD 0.61 a year ago.
For the six months, sales was TWD 327.33 million compared to TWD 407.87 million a year ago. Net loss was TWD 11.12 million compared to TWD 7.23 million a year ago. Basic loss per share from continuing operations was TWD 0.23 compared to TWD 0.15 a year ago. Diluted loss per share from continuing operations was TWD 0.23 compared to TWD 0.15 a year ago.
Health & Life Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of medical equipment. The Company's mainly provides electronic sphygmomanometers, such as blood pressure monitors, nebulizers and blood glucose monitoring systems, which are used to measure and record systolic and diastolic blood pressure and glucose of human beings. The Company distributes its products within domestic market and to overseas markets.